Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, based in Vancouver, BC, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany.
Satisfai will further develop AI software that will transform the management of Barrett’s Esophagus, critically the detection of early esophageal cancer when curable. Barrett’s is a gastrointestinal condition affecting around 150 million people globally. Terms of the transaction were not disclosed.